CPT Stock Analysis: Camden Property Trust | NYSE
REIT - Residential | NYSE, USA | Market Cap: 11.096m USD | 12M Return: 3.7% | US1331311027 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 97.6M
EPS Trend: -43.4%
Qual. Beats: 0
Rev. Trend: 94.4%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Camden Property Trust (NYSE: CPT) is an S&P 500 real estate company headquartered in Houston, Texas, that owns, operates, develops, and acquires multifamily apartment communities across the United States. The company is classified within the Multi-Family Residential REITs sub-industry under the GICS Real Estate sector.
As of the description, Camdens portfolio consists of 173 properties containing 58,811 apartment homes. With three properties currently under development, the portfolio is expected to expand to 59,973 apartment homes across 176 properties. The company was established on May 25, 1993, and trades as a large-cap common stock with a market capitalization of approximately $11.1 billion.
As a real estate investment trust (REIT), Camden operates under a business model that is generally required to distribute the majority of its taxable income to shareholders in the form of dividends. Its vertically integrated platform spans the full multifamily value chain, including ground-up development, redevelopment, acquisitions, and property management, allowing it to control multiple stages of the apartment investment lifecycle.
- Sun Belt job and population growth lifts apartment demand and rental rates
- Elevated new apartment supply pressures same-store occupancy and rent growth
- Higher interest rates increase borrowing costs and weigh on cap rate valuations
| Net Income: 326.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.27 > 1.0 |
| NWC/Revenue: -77.38% < 20% (prev -56.14%; Δ -21.24% < -1%) |
| CFO/TA 0.09 > 3% & CFO 807.4m > Net Income 326.2m |
| Net Debt (4.80b) to EBITDA (1.11b): 4.35 < 3 |
| Current Ratio: 0.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (102.4m) vs 12m ago -6.43% < -2% |
| Gross Margin: 22.38% > 18% (prev 61.19%; Δ -38.81% > 0.5%) |
| Asset Turnover: 16.94% > 50% (prev 17.11%; Δ -0.17% > 0%) |
| Interest Coverage Ratio: 3.30 > 6 (EBIT TTM 488.6m / Interest Expense TTM 147.9m) |
| A: -0.13 (Total Current Assets 52.8m - Total Current Liabilities 1.27b) / Total Assets 9.46b |
| B: -0.12 (Retained Earnings -1.13b / Total Assets 9.46b) |
| C: 0.05 (EBIT TTM 488.6m / Avg Total Assets 9.29b) |
| D: 0.68 (Book Value of Equity 3.80b / Total Liabilities 5.58b) |
| Altman-Z'' = -0.16 = B |
| DSRI: 0.90 (Receivables 8.05m/8.89m, Revenue 1.57b/1.56b) |
| GMI: 2.73 (GM 61.19% / 22.38%) |
| AQI: 2.53 (AQ_t 0.07 / AQ_t-1 0.03) |
| SGI: 1.01 (Revenue 1.57b / 1.56b) |
| TATA: -0.05 (NI 326.2m - CFO 807.4m) / TA 9.46b) |
| Beneish M = -0.63 (Cap -4..+1) = D |
As of August 22, 2026, the stock is trading at USD 107.59 with a total of 832,109 shares traded. Over the past week, the price has changed by -2.51%, over one month by -4.01%, over three months by +2.27% and over the past year by +3.66%.
Current recommended Stop Loss: 104.50 (which is 2.9% or 1.5 ATR below the current price).
Camden Property Trust has received a consensus analysts rating of 3.68. Therefore, it is recommended to hold CPT.
- StrongBuy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 117.4 | 9.1% |
P/E Trailing = 36.4224
P/E Forward = 69.4444
P/S = 7.0142
P/B = 2.9182
P/EG = 9.1681
Revenue TTM = 1.57b USD
EBIT TTM = 488.6m USD
EBITDA TTM = 1.11b USD
Long Term Debt = 3.90b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.16b USD (from shortTermDebt, last fiscal year)
Debt = 4.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.80b USD (calculated: Debt 4.85b - CCE 44.7m)
Enterprise Value = 15.9b USD (11.1b + Debt 4.85b - CCE 44.7m)
Interest Coverage Ratio = 3.30 (Ebit TTM 488.6m / Interest Expense TTM 147.9m)
EV/FCF = 30.08x (Enterprise Value 15.9b / FCF TTM 528.6m)
FCF Yield = 3.32% (FCF TTM 528.6m / Enterprise Value 15.9b)
FCF Margin = 33.59% (FCF TTM 528.6m / Revenue TTM 1.57b)
Net Margin = 20.73% (Net Income TTM 326.2m / Revenue TTM 1.57b)
Gross Margin = 22.38% ((Revenue TTM 1.57b - Cost of Revenue TTM 1.22b) / Revenue TTM)
Gross Margin QoQ = -17.92% (prev -15.38%)
Tobins Q-Ratio = 1.68 (Enterprise Value 15.9b / Total Assets 9.46b)
Interest Expense / Debt = 3.05% (Interest Expense 147.9m / Debt 4.85b)
Taxrate = 0.55% (1.89m / 341.1m)
NOPAT = 485.9m (EBIT 488.6m * (1 - 0.55%))
Current Ratio = 0.03 (Total Current Assets 52.8m / Total Current Liabilities 1.52b)
Debt / Equity = 1.28 (Debt 4.85b / totalStockholderEquity, last quarter 3.80b)
Debt / EBITDA = 4.35 (Net Debt 4.80b / EBITDA 1.11b)
Debt / FCF = 9.09 (Net Debt 4.80b / FCF TTM 528.6m)
Total Stockholder Equity = 4.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.51% (Net Income 326.2m / Total Assets 9.46b)
RoE = 7.80% (Net Income TTM 326.2m / Total Stockholder Equity 4.18b)
RoCE = 6.04% (EBIT 488.6m / Capital Employed (Equity 4.18b + L.T.Debt 3.90b))
RoIC = 4.60% (NOPAT 485.9m / Invested Capital 10.6b)
WACC = 5.20% (E(11.1b)/V(15.9b) * Re(6.14%) + D(4.85b)/V(15.9b) * Rd(3.05%) * (1-Tc(0.01)))
Discount Rate = 6.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -66.11 | Cagr: -2.65%
[DCF] Terminal Value 77.97% ; FCFF base≈474.9m ; Y1≈544.3m ; Y5≈801.1m
[DCF] Fair Price = 72.13 (EV 12.1b - Net Debt 4.80b = Equity 7.25b / Shares 100.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -43.39 | EPS CAGR: -12.36% | SUE: 0.05 | # QB: 0
Revenue Correlation: 94.38 | Revenue CAGR: 1.00% | SUE: 1.40 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.30 | Chg30d=-31.81% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=2.30 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+79.1% | GrowthRev=-1.5%
EPS next Year (2027-12-31): EPS=1.09 | Chg30d=+38.85% | Revisions=-25% | GrowthEPS=-52.5% | GrowthRev=+1.0%
[Analyst] Revisions Ratio: -40% (up=0, down=2)